The Acute Respiratory Distress Syndrome (ARDS) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Acute Respiratory Distress Syndrome (ARDS) Market?
The market size of the acute respiratory distress syndrome (ARDS) has seen significant growth recently. The market value is expected to elevate from $1.29 billion in 2024 to $1.42 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Acute Respiratory Distress Syndrome (ARDS) Industry?
The global market for acute respiratory distress syndrome (ARDS) is projected to expand to $2.17 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.1%.
Download Your Free Sample of the 2025 Acute Respiratory Distress Syndrome (ARDS) Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Acute Respiratory Distress Syndrome (ARDS) Market?
The key drivers in the acute respiratory distress syndrome (ards) market are:
• Global healthcare preparedness initiatives
• Advancements in vaccine development and infectious disease management
• Integration of telemedicine and remote monitoring systems
• Emergence of patient-centered care models
Global Market Segmentation: Identifying Major Acute Respiratory Distress Syndrome (ARDS) Industry Segments
The acute respiratory distress syndrome (ARDS) market covered in this report is segmented –
1) By Type: Diagnosis, Treatment
2) By Cause: COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes
3) By Severity: Mild, Moderate, Severe
4) By End User: Hospitals, Clinics, Ambulatory Service Centers, Other End Users
Pre-order the 2025 Acute Respiratory Distress Syndrome (ARDS) Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Acute Respiratory Distress Syndrome (ARDS) Market?
The key trends in the acute respiratory distress syndrome (ards) market are:
• Artificial lung devices are emerging as a significant trend in the ARDS market.
• Personalized ventilation strategies are tipped to shape the future of the ARDS market.
• Lung protective ventilation techniques are a growing trend in this sphere.
• Development and implementation of specific drug therapies for different ARDS subtypes is a noteworthy upcoming trend.
Who Are the Top Competitors & Leading Players in the Acute Respiratory Distress Syndrome (ARDS) Market?
Major companies in the acute respiratory distress syndrome (ards) market are:
• Johnson & Johnson Services Inc.
• Novartis AG
• GlaxoSmithKline PLC
• Medtronic PLC
• Boehringer Ingelheim International GmbH
• Gilead Sciences Inc.
• Amgen Inc.
• Fresenius SE & Co. KGaA
• Koninklijke Philips N.V.
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• CSL Behring
• Terumo Corporation
• ResMed Inc.
• Smiths Medical Inc.
• Dräger Safety AG & Co. KGaA.
• Getinge AB
• Mallinckrodt PLC
• Masimo Corporation
• United Therapeutics Corporation
• Fisher & Paykel Healthcare Corporation Limited
• Hamilton Medical AG
• Zuventus Healthcare Ltd.
• Windtree Therapeutics Inc.
• Faron Pharmaceuticals Oy
• AcelRx Pharmaceuticals Inc.
Regional Dominance: Which Area Leads the Global Acute Respiratory Distress Syndrome (ARDS) Market?
North America was the largest region in the acute respiratory distress syndrome (ARDS) market in 2024
